Market Exclusive

Analyst Activity – Ladenburg Thalmann Financial Services Raises Its Price Target On Corcept Therapeutics Incorporated (NASDAQ:CORT) to

Analyst Ratings For Corcept Therapeutics Incorporated (NASDAQ:CORT)

Today, Ladenburg Thalmann Financial Services raised its price target on Corcept Therapeutics Incorporated (NASDAQ:CORT) to per share.

There are 1 sell rating, 3 buy ratings on the stock.

The current consensus rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) is Buy (Score: 2.50) with a consensus target price of $14.25 per share, a potential 17.19% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Corcept Therapeutics Incorporated (NASDAQ:CORT)
Corcept Therapeutics Incorporated (NASDAQ:CORT) has insider ownership of 19.20% and institutional ownership of 53.52%.

Recent Trading Activity for Corcept Therapeutics Incorporated (NASDAQ:CORT)
Shares of Corcept Therapeutics Incorporated closed the previous trading session at 12.42 up +0.26 2.14% with 451,578 shares trading hands.

Exit mobile version